{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T22:05:47Z","timestamp":1770069947820,"version":"3.49.0"},"reference-count":169,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.lpm.2010.12.012","type":"journal-article","created":{"date-parts":[[2011,2,23]],"date-time":"2011-02-23T05:03:02Z","timestamp":1298437382000},"page":"e257-e270","source":"Crossref","is-referenced-by-count":21,"special_numbering":"P2","title":["Therapy of polymyositis and dermatomyositis"],"prefix":"10.1016","volume":"40","author":[{"given":"Isabelle","family":"Marie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2010.12.012_bib0005","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/S0755-4982(04)98952-X","article-title":"Physiopathologie des myopathies inflamamtoires idiopathiques","volume":"33","author":"Benveniste","year":"2004","journal-title":"Presse Med"},{"key":"10.1016\/j.lpm.2010.12.012_bib0010","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(99)05157-0","article-title":"Dermatomyositis","volume":"355","author":"Callen","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2010.12.012_bib0015","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.revmed.2005.02.002","article-title":"Les nouveaux crit\u00e8res diagnostiques et d\u2019\u00e9valuation des polymyosites et dermatomyosites","volume":"26","author":"Ch\u00e9rin","year":"2005","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.lpm.2010.12.012_bib0020","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.lpm.2009.01.013","article-title":"Myopathies inflammatoires\u00a0: diagnostic et classifications","volume":"38","author":"Dimitri","year":"2009","journal-title":"Presse Med"},{"key":"10.1016\/j.lpm.2010.12.012_bib0025","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.lpm.2008.09.021","article-title":"Infections au cours des polymyosites et des dermatomyosites","volume":"38","author":"Marie","year":"2009","journal-title":"Presse Med"},{"key":"10.1016\/j.lpm.2010.12.012_bib0030","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0755-4982(06)74663-2","article-title":"Atteinte pulmonaire au cours des polymyosites et des dermatomyosites\u00a0: la pneumopathie interstitielle","volume":"35","author":"Marie","year":"2006","journal-title":"Presse Med"},{"key":"10.1016\/j.lpm.2010.12.012_bib0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/art.21083","article-title":"Opportunistic infections in polymyositis and dermatomyositis","volume":"53","author":"Marie","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.12.012_bib0040","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/art.10794","article-title":"Interstitial lung disease in polymyositis and dermatomyositis","volume":"47","author":"Marie","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.12.012_bib0045","first-page":"2230","article-title":"Polymyositis and dermatomyositis: short-term and long-term outcome, and predictive factors","volume":"28","author":"Marie","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0050","first-page":"1336","article-title":"Pulmonary involvement in polymyositis and in dermatomyositis","volume":"25","author":"Marie","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0055","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-199905000-00001","article-title":"Influence of age on characteristics of polymyositis and dermatomyositis in adults","volume":"78","author":"Marie","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.lpm.2010.12.012_bib0060","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2133.2009.09484.x","article-title":"Long-term outcome of patients with polymyositis\/dermatomyositis and anti-PM-Scl antibody","volume":"162","author":"Marie","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0065","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis I","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2010.12.012_bib0070","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis II","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2010.12.012_bib0075","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.410160206","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells","volume":"16","author":"Arahata","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0080","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ana.410190203","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies. III: Immunoelectron microscopy aspects of cell-mediated muscle fiber injury","volume":"19","author":"Arahata","year":"1986","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0085","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1172\/JCI118749","article-title":"Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis","volume":"97","author":"Goebels","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lpm.2010.12.012_bib0090","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrrheum.2010.2","article-title":"Immunotherapy of myositis: issues, concerns and future prospects","volume":"6","author":"Dalakas","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0095","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0046-8177(89)90128-7","article-title":"Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies","volume":"20","author":"Emslie-Smith","year":"1989","journal-title":"Hum Pathol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0100","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1084\/jem.6.4-6.407","article-title":"Dermatomyositis with a report of case which presented a rare anomaly but once described in man","volume":"6","author":"Steiner","year":"1903","journal-title":"J Exp Med"},{"key":"10.1016\/j.lpm.2010.12.012_bib0105","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/archderm.1940.01490120003001","article-title":"Dermatomyositis: a study of 40 cases","volume":"41","author":"O\u2019Leary","year":"1940","journal-title":"Arch Dermatol Syphil"},{"key":"10.1016\/j.lpm.2010.12.012_bib0110","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/art.1780280303","article-title":"Prognostic factors in polymyositis\/dermatomyositis. A computer-assisted analysis of ninety-two cases","volume":"28","author":"Benbassat","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.12.012_bib0115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00005792-197707000-00001","article-title":"Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis","volume":"56","author":"Bohan","year":"1977","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.lpm.2010.12.012_bib0120","first-page":"207","article-title":"Survival in polymyositis: corticosteroids and risk factors","volume":"4","author":"Carpenter","year":"1977","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0125","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/art.1780261208","article-title":"Mortality from polymyositis and dermatomyositis in the United States, 1968\u20131978","volume":"26","author":"Hochberg","year":"1983","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.12.012_bib0130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/art.1780140210","article-title":"Factors affecting survivorship in polymyositis. A life-table study of 124 patients","volume":"14","author":"Medsger","year":"1971","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.lpm.2010.12.012_bib0135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0022-510X(75)90115-X","article-title":"Prognosis in adult polymyositis","volume":"26","author":"Riddoch","year":"1975","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.lpm.2010.12.012_bib0140","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/brain\/89.4.747","article-title":"Polymyositis: a survey of 89 cases with particular reference to treatment and prognosis","volume":"89","author":"Rose","year":"1966","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2010.12.012_bib0145","first-page":"CD003643","article-title":"Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis","volume":"3","author":"Choy","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.lpm.2010.12.012_bib0150","first-page":"157","article-title":"Dermatomyositis: diagnosis, evaluation and management","volume":"93","author":"Callen","year":"2002","journal-title":"Minerva Med"},{"key":"10.1016\/j.lpm.2010.12.012_bib0155","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/rheumatology\/41.1.7","article-title":"Treatment of dermatomyositis and polymyositis","volume":"41","author":"Choy","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2010.12.012_bib0160","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/brain\/98.4.637","article-title":"Polymyositis: its presentation, morbidity and mortality","volume":"98","author":"DeVere","year":"1975","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2010.12.012_bib0165","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaad.2008.02.043","article-title":"The treatment and prognosis of dermatomyositis: an updated review","volume":"59","author":"Iorizzo","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0170","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/mus.10313","article-title":"Inflammatory myopathies: clinical, diagnostic and therapeutic aspects","volume":"27","author":"Mastaglia","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.lpm.2010.12.012_bib0175","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0301-0082(90)90026-D","article-title":"Polymyositis and dermatomyositis 1990: diagnosis, treatment and prognosis","volume":"35","author":"Henriksson","year":"1990","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0180","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1600-0404.1982.tb03087.x","article-title":"Polymyositis: treatment and prognosis. A study of 107 patients","volume":"65","author":"Henriksson","year":"1982","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.lpm.2010.12.012_bib0185","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0002-9343(93)90148-I","article-title":"Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy","volume":"94","author":"Joffe","year":"1993","journal-title":"Am J Med"},{"key":"10.1016\/j.lpm.2010.12.012_bib0190","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","article-title":"Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients","volume":"84","author":"Troyanov","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.lpm.2010.12.012_bib0195","first-page":"507","article-title":"Param\u00e8tres pharmacocin\u00e9tiques de la prednisone et de la prednisolone chez le volontaire sain","volume":"141","author":"Etienne","year":"1990","journal-title":"Ann Med Interne"},{"key":"10.1016\/j.lpm.2010.12.012_bib0200","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0190-9622(96)90037-7","article-title":"Guidelines of care for dermatomyositis. American Academy of Dermatology","volume":"34","author":"Drake","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0205","first-page":"807","article-title":"Relationship between serum creatine kinase level and corticosteroid therapy in polymyositis-dermatomyositis","volume":"15","author":"Oddis","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0210","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/art.1780380907","article-title":"A longitudinal study of functional disability in a national cohort of patients with polymyositis\/dermatomyositis","volume":"38","author":"Clarke","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.12.012_bib0215","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0738-081X(88)90044-2","article-title":"History and classification of polymyositis and dermatomyositis","volume":"6","author":"Bohan","year":"1988","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0220","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1136\/jnnp.57.8.1008","article-title":"Pulsed intravenous methylprednisolone combined with oral steroids as the initial treatment of inflammatory myopathies","volume":"57","author":"Matsubara","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2010.12.012_bib0225","first-page":"1214","article-title":"The treatment of dermatomyositis with hydroxchloroquine","volume":"12","author":"James","year":"1985","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0230","first-page":"1545","article-title":"Adjunctive use of hydroxychloroquine in childhood dermatomyositis","volume":"16","author":"Olson","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0235","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0190-9622(84)80263-7","article-title":"Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine","volume":"10","author":"Woo","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0240","first-page":"102","article-title":"Regression of cutis calcinosis with diltiazem in adult dermatomyositis","volume":"15","author":"Abdallah-Lotf","year":"2005","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0245","first-page":"1837","article-title":"Rapid improvement of calcinosis in juvenile dermatomyositis with alendronate therapy","volume":"32","author":"Ambler","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0250","first-page":"1129","article-title":"Treatment of calcinosis in juvenile dermatomyositis with probenecid: the role of phosphorus metabolism in the development of calcifications","volume":"28","author":"Harel","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0255","first-page":"135","article-title":"Effectiveness of the treatment with intravenous pamidronate in calcinosis in juvenile dermatomyositis","volume":"28","author":"Marco Puche","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0260","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jbspin.2009.04.011","article-title":"Complete resolution of universal calcinosis in a patient with juvenile dermatomyositis using pamidronate","volume":"77","author":"Slimani","year":"2010","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.lpm.2010.12.012_bib0265","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/art.1780240107","article-title":"Prednisone and azathioprine for polymyositis: long-term follow-up","volume":"24","author":"Bunch","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.12.012_bib0270","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/088307389801300303","article-title":"Drug therapy in juvenile dermatomyositis: follow-up study","volume":"13","author":"Ng","year":"1998","journal-title":"J Child Neurol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0275","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0049-0172(90)90024-A","article-title":"Adult-onset polymyositis-dermatomyositis: description of 25 patients with emphasis on treatment","volume":"20","author":"Ram\u00edrez","year":"1990","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.12.012_bib0280","first-page":"S53","article-title":"Randomised double-blind controlled trial of methotrexate and steoids compared with azathioprine and steroids in the treatment of idiopathic inflamamtory myopathy","volume":"199","author":"Miller","year":"2002","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.lpm.2010.12.012_bib0285","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/ard.41.6.557","article-title":"Intensive immunosuppression versus prednisolone in the treatment of connective tissue diseases","volume":"41","author":"Hollingworth","year":"1982","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2010.12.012_bib0290","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/0003-4819-92-3-365","article-title":"Azathioprine with prednisone for polymyositis. A controlled, clinical trial","volume":"92","author":"Bunch","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2010.12.012_bib0295","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(68)90649-1","article-title":"Treatment of dermatomyositis with methotrexate","volume":"2","author":"Malaviya","year":"1968","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2010.12.012_bib0300","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/ard.32.6.536","article-title":"Methotrexate therapy in polymyositis","volume":"32","author":"Arnett","year":"1973","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2010.12.012_bib0305","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/archderm.1979.04010100055023","article-title":"Treatment of dermatomyositis with methotrexate and prednisone","volume":"115","author":"Giannini","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0310","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0190-9622(97)70327-X","article-title":"Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis","volume":"36","author":"Kasteler","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0315","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7326\/0003-4819-81-2-182","article-title":"Polymyositis and dermatomyositis: combined methotrexate and corticosteroid therapy","volume":"81","author":"Metzger","year":"1974","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2010.12.012_bib0320","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/art.1780351006","article-title":"Methotrexate treatment of recalcitrant childhood dermatomyositis","volume":"35","author":"Miller","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.12.012_bib0325","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000114893","article-title":"Methotrexate treatment in dermatomyositis","volume":"16","author":"Sarova-Pinhas","year":"1977","journal-title":"Eur Neurol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0330","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(71)80005-3","article-title":"Treatment of corticosteroid-resistant polymyositis with methotrexate","volume":"1","author":"Sokoloff","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2010.12.012_bib0335","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/1529-0131(199803)41:3<392::AID-ART3>3.0.CO;2-X","article-title":"Treatment of refractory myositis: a randomized crossover study of two new cytotoxic regimens","volume":"41","author":"Villalba","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.12.012_bib0340","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/0190-9622(95)91455-2","article-title":"Treatment of dermatomyositis with methotrexate","volume":"32","author":"Zieglschmid-Adams","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0345","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0190-9622(98)70562-6","article-title":"The value of methotrexate in dermatomyositis","volume":"38","author":"Zieglschmid-Adams","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0350","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1468-1331.2008.02246.x","article-title":"EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases","volume":"15","author":"Elovaara","year":"2008","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0355","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0091-6749(89)90199-1","article-title":"The use of intravenous immune globulin in collagen vascular disorders: a potentially new modality of therapy","volume":"84","author":"Gelfand","year":"1989","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0360","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0002-9343(91)90009-M","article-title":"Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients","volume":"91","author":"Cherin","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.lpm.2010.12.012_bib0365","first-page":"1092","article-title":"Intravenous gamma globulin as first-line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients","volume":"21","author":"Cherin","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0370","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/jnnp.55.1.60","article-title":"High-dose intravenous human immunoglobulin in polymyositis resistant to treatment","volume":"55","author":"Jann","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2010.12.012_bib0375","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0002-9343(91)90010-U","article-title":"Treatment of dermatomyositis with intravenous gammaglobulin","volume":"91","author":"Lang","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.lpm.2010.12.012_bib0380","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jnnp.65.1.107","article-title":"Immunoglobulin therapy in inflammatory myopathies","volume":"65","author":"Mastaglia","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2010.12.012_bib0385","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/adc.72.1.25","article-title":"Intravenous immunoglobulin in juvenile dermatomyositis: four-year review of nine cases","volume":"72","author":"Sansome","year":"1995","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.lpm.2010.12.012_bib0390","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","article-title":"A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis","volume":"329","author":"Dalakas","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2010.12.012_bib0395","first-page":"2706","article-title":"Intravenous immunoglobulins as treatment of life-threatening esophageal involvement in polymyositis and dermatomyositis","volume":"26","author":"Marie","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0400","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/acr.20325","article-title":"Intravenous immunoglobulins for steroid-refractiry esophageal involvement related to polymyositis and dermatomyositis. A series of 73 patients","volume":"62","author":"Marie","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.lpm.2010.12.012_bib0405","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/ard.61.1.37","article-title":"Cyclosporin A and intravenous immunoglobulin treatment in polymyositis\/dermatomyositis","volume":"61","author":"Danieli","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2010.12.012_bib0410","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/jnnp.54.11.1007","article-title":"Cyclosporin in the management of polymyositis and dermatomyositis","volume":"54","author":"Lueck","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2010.12.012_bib0415","first-page":"2855","article-title":"in the treatment of refractory adult polymyositis\/dermatomyositis: population based experience in 6 patients and literature review","volume":"27","author":"Qushmaq","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0420","first-page":"2436","article-title":"Preliminary evidence for cyclosporin A as an alternative in the treatment of recalcitrant juvenile rheumatoid arthritis and juvenile dermatomyositis","volume":"24","author":"Reiff","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0425","first-page":"449","article-title":"The efficacy of cyclosporin in the treatment of myositis","volume":"195","author":"S\u00e1nchez Rom\u00e1n","year":"1995","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.lpm.2010.12.012_bib0430","first-page":"1424","article-title":"Cyclosporin a therapy in refractory juvenile dermatomyositis. Experience and long-term follow-up of 6 cases","volume":"23","author":"Zeller","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0435","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0140-6736(84)91301-1","article-title":"Cyclosporin for polymyositis","volume":"1","author":"Bendtzen","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2010.12.012_bib0440","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/ard.45.7.612-b","article-title":"Severe dermatomyositis treated with cyclosporin A","volume":"45","author":"Ejstrup","year":"1986","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2010.12.012_bib0445","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/rheumatology\/32.5.439","article-title":"Cyclosporin A in adult dermatomyositis","volume":"32","author":"Keen","year":"1993","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0450","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/rheumatology\/31.12.855","article-title":"A case of adult dermatomyositis treated with cyclosporin A","volume":"31","author":"Pugh","year":"1992","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0455","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/art.1780340726","article-title":"Cyclosporin A treatment of dermatomyositis","volume":"34","author":"Danko","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.12.012_bib0460","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0140-6736(84)90391-X","article-title":"Cyclosporin for acute dermatomyositis","volume":"1","author":"Zabel","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2010.12.012_bib0465","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/030097400750001897","article-title":"Cyclosporin A versus methotrexate in the treatment of polymyositis and dermatomyositis","volume":"29","author":"Vencovsk\u00fd","year":"2000","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0470","first-page":"58","article-title":"Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis","volume":"32","author":"Fujisawa","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0475","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/rheumatology\/keg040","article-title":"Interstitial lung disease associated with juvenile dermatomyositis: clinical features and efficacy of cyclosporin A","volume":"42","author":"Kobayashi","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2010.12.012_bib0480","first-page":"24","article-title":"Early intervention with corticosteroids and cyclosporin A and 2-hour postdose blood concentration monitoring improves the prognosis of acute\/subacute interstitial pneumonia in dermatomyositis","volume":"35","author":"Kotani","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0485","first-page":"128","article-title":"Usefulness of cyclosporine A on rapidly progressive interstitial pneumonia in dermatomyositis","volume":"19","author":"Miyake","year":"2002","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.lpm.2010.12.012_bib0490","first-page":"1527","article-title":"Corticosteroid-resistant interstitial pneumonitis in dermatomyositis\/polymyositis: prediction and treatment with cyclosporine","volume":"26","author":"Nawata","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0495","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1191\/0961203305lu2158oa","article-title":"Polymyositis\/dermatomyositis-associated lung disease: analysis of a series of 81 patients","volume":"14","author":"Selva-O\u2019Callaghan","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2010.12.012_bib0500","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/08916930500124023","article-title":"Polymyositis\/dermatomyositis and interstitial lung disease: a new therapeutic approach with T-cell-specific immunosuppressants","volume":"38","author":"Takada","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1016\/j.lpm.2010.12.012_bib0505","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2152\/jmi.54.295","article-title":"Comparison of clinical course of polymyositis and dermatomyositis: a follow-up in Tokushima University Hospital","volume":"54","author":"Tani","year":"2007","journal-title":"J Med Invest"},{"key":"10.1016\/j.lpm.2010.12.012_bib0510","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3109\/03009749709065660","article-title":"Cyclosporine treatment for polymyositis\/dermatomyositis: is it possible to rescue the deteriorating cases with interstitial pneumonitis?","volume":"26","author":"Maeda","year":"1997","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0515","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0140-6736(89)92416-1","article-title":"Cyclophosphamide in severe polymyositis","volume":"1","author":"Bombardieri","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2010.12.012_bib0520","first-page":"205","article-title":"Polymyositis-dermatomyositis: a 25-year follow-up of 50 patients (analysis of clinical symptoms and signs and results of laboratory tests)","volume":"22","author":"Chwali\u0144ska-Sadowska","year":"1990","journal-title":"Mater Med Pol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0525","first-page":"1225","article-title":"The failure of intravenous cyclophosphamide therapy in refractory idiopathic inflammatory myopathy","volume":"16","author":"Cronin","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0530","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/ard.52.12.857","article-title":"Adult onset polymyositis\/dermatomyositis: clinical and laboratory features and treatment response in 75 patients","volume":"52","author":"Koh","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2010.12.012_bib0535","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/rheumatology\/kel112","article-title":"Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis\/dermatomyositis","volume":"46","author":"Yamasaki","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2010.12.012_bib0540","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1053\/sarh.2002.50012","article-title":"Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment","volume":"32","author":"Schnabel","year":"2003","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.12.012_bib0545","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5387\/fms.48.103","article-title":"Prevention of progression of interstitial lung lesions by early combination therapy with corticosteroids and cyclosporine\/cyclophosphamide in two patients with amyopathic dermatomyositis","volume":"48","author":"Sugisaki","year":"2002","journal-title":"Fukushima J Med Sci"},{"key":"10.1016\/j.lpm.2010.12.012_bib0550","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2169\/internalmedicine.39.428","article-title":"Successful combined therapy of cyclophosphamide and cyclosporine for acute exacerbated interstitial pneumonia associated with dermatomyositis","volume":"39","author":"Tanaka","year":"2000","journal-title":"Intern Med"},{"key":"10.1016\/j.lpm.2010.12.012_bib0555","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2169\/internalmedicine.38.733","article-title":"Pulse intravenous cyclophosphamide treatment for steroid-resistant interstitial pneumonitis associated with polymyositis","volume":"38","author":"Yoshida","year":"1999","journal-title":"Intern Med"},{"key":"10.1016\/j.lpm.2010.12.012_bib0560","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/1529-0131(199807)41:7<1215::AID-ART11>3.0.CO;2-Y","article-title":"Intravenous pulse cyclophosphamide in the treatment of interstitial lung disease due to collagen vascular diseases","volume":"41","author":"Schnabel","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.12.012_bib0565","first-page":"1719","article-title":"Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute\/subacute interstitial pneumonia in patients with dermatomyositis","volume":"32","author":"Kameda","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0570","first-page":"41","article-title":"Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies","volume":"139","author":"Bandelier","year":"2009","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.lpm.2010.12.012_bib0575","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s10067-006-0526-5","article-title":"Long-standing refractory polymyositis responding to mycophenolate mofetil: a case report and review of the literature","volume":"26","author":"Caramaschi","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0580","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archderm.142.1.65","article-title":"Mycophenolate mofetil as an effective corticosteroid-sparing therapy for recalcitrant dermatomyositis","volume":"142","author":"Edge","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0585","first-page":"1542","article-title":"Mycophenolate mofetil in the treatment of severe skin manifestations of dermatomyositis: a series of 4 cases","volume":"27","author":"Gelber","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0590","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/rheumatology\/keh499","article-title":"Mycophenolate mofetil (CellCept): an alternative therapy for autoimmune inflammatory myopathy","volume":"44","author":"Majithia","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2010.12.012_bib0595","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/rheumatology\/kel336","article-title":"Mycophenolate mofetil treatment in resistant myositis","volume":"46","author":"Pisoni","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2010.12.012_bib0600","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000051674","article-title":"Mycophenolate mofetil for dermatomyositis","volume":"202","author":"Tausche","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.lpm.2010.12.012_bib0605","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0012-3692(15)50949-5","article-title":"Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease","volume":"130","author":"Swigris","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2010.12.012_bib0610","doi-asserted-by":"crossref","unstructured":"Marie I, Menard JF, Hachulla E, Cherin P, Benveniste O, Tiev K, et al. Infectious complications in polymyositis and dermatomyositis. A series of 279 patients. Semin Arthritis Rheum 2010, doi:10.1016\/j.semarthrit.2010.08.003.","DOI":"10.1016\/j.semarthrit.2010.08.003"},{"key":"10.1016\/j.lpm.2010.12.012_bib0615","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1212\/01.wnl.0000208416.32471.c0","article-title":"Mycophenolate mofetil in dermatomyositis: is it safe?","volume":"66","author":"Rowin","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2010.12.012_bib0620","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jaad.2007.08.014","article-title":"Leflunomide as adjuvant treatment of dermatomyositis","volume":"58","author":"Boswell","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0625","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/08916930600623874","article-title":"Anti-Jo-1 antibody positive polymyositis: successful therapy with leflunomide","volume":"39","author":"Lange","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.lpm.2010.12.012_bib0630","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/S0140-6736(99)01927-3","article-title":"Tacrolimus in refractory polymyositis with interstitial lung disease","volume":"353","author":"Oddis","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2010.12.012_bib0635","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s10067-004-0865-z","article-title":"Efficacy of tacrolimus in treatment of polymyositis associated with myasthenia gravis","volume":"23","author":"Shimojima","year":"2004","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0640","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00431-004-1497-7","article-title":"Steroid-sparing effect of tacrolimus in a patient with juvenile dermatomyositis presenting poor bioavailability of cyclosporine A","volume":"163","author":"Yamada","year":"2004","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.lpm.2010.12.012_bib0645","first-page":"270","article-title":"Plasma exchange in polymyositis and dermatomyositis: a multicenter study of 57 cases","volume":"13","author":"Cherin","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0650","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1056\/NEJM199205213262102","article-title":"Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis","volume":"326","author":"Miller","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2010.12.012_bib0655","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/rheumatology\/keh539","article-title":"Advanced refractory polymyositis responding to infliximab","volume":"44","author":"Anandacoomarasamy","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2010.12.012_bib0660","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1007\/s10067-006-0325-z","article-title":"Treatment of early and refractory dermatomyositis with infliximab: a report of two cases","volume":"26","author":"Dold","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0665","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/ard.2005.048744","article-title":"Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients","volume":"65","author":"Efthimiou","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2010.12.012_bib0670","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000070852","article-title":"Successful treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: preliminary observations","volume":"50","author":"Hengstman","year":"2003","journal-title":"Eur Neurol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0675","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/rheumatology\/keh226","article-title":"Successful treatment of alveolar hypoventilation due to dermatomyositis with anti-tumour necrosis factor-alpha","volume":"43","author":"Korkmaz","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2010.12.012_bib0680","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/rheumatology\/keh079","article-title":"Refractory polymyositis responding to infliximab: extended follow-up","volume":"43","author":"Labioche","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2010.12.012_bib0685","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/rheumatology\/ken074","article-title":"Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis","volume":"47","author":"Riley","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2010.12.012_bib0690","first-page":"1802","article-title":"Use of etanercept in the treatment of dermatomyositis: a case series","volume":"33","author":"Iannone","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0695","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/rheumatology\/keh062","article-title":"Treatment of myositis with etanercept (Enbrel), a recombinant human soluble fusion protein of TNF-alpha type II receptor and IgG1","volume":"43","author":"Sprott","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2010.12.012_bib0700","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/ard.2007.077974","article-title":"A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies","volume":"67","author":"Dastmalchi","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2010.12.012_bib0705","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/art.20849","article-title":"Rituximab in the treatment of dermatomyositis: an open-label pilot study","volume":"52","author":"Levine","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.12.012_bib0710","unstructured":"Marie I. Connectivites et pseudo-connectivites d\u2019origine m\u00e9dicamenteuse et toxique. Les diagnostics difficiles en m\u00e9decine interne. \u00c9ditions Maloine (3e \u00e9dition); 2008. p.\u00a0179\u201396."},{"key":"10.1016\/j.lpm.2010.12.012_bib0715","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000114036","article-title":"Open-label trial of anti-TNF-alpha in dermato- and polymyositis treated concomitantly with methotrexate","volume":"59","author":"Hengstman","year":"2008","journal-title":"Eur Neurol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0720","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/archdermatol.2010.142","article-title":"Tumor necrosis factor inhibitor-associated dermatomyositis","volume":"146","author":"Klein","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0725","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1002\/art.22860","article-title":"A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52\/anti-Ro 60 autoantibodies","volume":"56","author":"Eloranta","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.12.012_bib0730","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/rheumatology\/keh700","article-title":"Fatal Mycobacterium peregrinum pneumonia in refractory polymyositis treated with infliximab","volume":"44","author":"Marie","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2010.12.012_bib0735","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jbspin.2007.07.010","article-title":"Antisynthetase syndrome with refractory polyarthritis and fever successfully treated with the IL-1 receptor antagonist, anakinra: a case report","volume":"75","author":"Furlan","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.lpm.2010.12.012_bib0740","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.nmd.2006.03.002","article-title":"Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP)","volume":"16","author":"Arlet","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.lpm.2010.12.012_bib0745","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/ard.2005.045898","article-title":"Rituximab in the treatment of antisynthetase syndrome","volume":"65","author":"Brulhart","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2010.12.012_bib0750","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/01.rhu.0000182155.08982.60","article-title":"Rituximab in the treatment of refractory dermatomyositis","volume":"11","author":"Chiappetta","year":"2005","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0755","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/archderm.143.6.763","article-title":"A pilot trial of rituximab in the treatment of patients with dermatomyositis","volume":"143","author":"Chung","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0760","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jaad.2006.05.068","article-title":"Rituximab for the treatment of the skin manifestations of dermatomyositis: a report of 3 cases","volume":"56","author":"Dinh","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0765","first-page":"1369","article-title":"Efficacy of rituximab in refractory polymyositis","volume":"32","author":"Lambotte","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0770","first-page":"1864","article-title":"Rituximab for refractory polymyositis: an open-label prospective study","volume":"34","author":"Mok","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0775","first-page":"1021","article-title":"Rituximab as therapy for refractory polymyositis and dermatomyositis","volume":"33","author":"Noss","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0780","first-page":"887","article-title":"Clinical outcome following B cell depletion therapy in eight patients with refractory idiopathic inflammatory myopathy","volume":"26","author":"Sultan","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0785","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/rheumatology\/kep147","article-title":"Efficacy of rituximab in refractory and relapsing myositis with anti-JO1 antibodies: a report of two cases","volume":"48","author":"Frikha","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2010.12.012_bib0790","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/ard.2004.029694","article-title":"Tolerance and short-term efficacy of rituximab in 43 patients with systemic autoimmune diseases","volume":"64","author":"Gottenberg","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2010.12.012_bib0795","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jbspin.2007.05.011","article-title":"Successful treatment of cardiac involvement in dermatomyositis with rituximab","volume":"75","author":"Touma","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.lpm.2010.12.012_bib0800","first-page":"1230","article-title":"Long-lasting remissions after treatment with rituximab for autoimmune myositis","volume":"35","author":"Feist","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0805","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/rheumatology\/kep157","article-title":"Rituximab treatment of the antisynthetase syndrome: a retrospective case series","volume":"48","author":"Sem","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2010.12.012_bib0810","first-page":"2080","article-title":"Alemtuzumab (Campath-1H) for treatment of refractory polymyositis","volume":"35","author":"Thompson","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0815","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/030097400447679","article-title":"The safety of a resistive home exercise program in patients with recent onset active polymyositis or dermatomyositis","volume":"29","author":"Alexanderson","year":"2000","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0820","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/rheumatology\/38.7.608","article-title":"Safety of a home exercise programme in patients with polymyositis and dermatomyositis: a pilot study","volume":"38","author":"Alexanderson","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2010.12.012_bib0825","first-page":"1340","article-title":"Resistive exercise in the rehabilitation of polymyositis\/dermatomyositis","volume":"20","author":"Escalante","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0830","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/rheumatology\/37.2.196","article-title":"Improvement of physical fitness and muscle strength in polymyositis\/dermatomyositis patients by a training programme","volume":"37","author":"Wiesinger","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0835","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/rheumatology\/37.12.1338","article-title":"Benefit of 6months long-term physical training in polymyositis\/dermatomyositis patients","volume":"37","author":"Wiesinger","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.lpm.2010.12.012_bib0840","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/art.21185","article-title":"Safety and efficacy of submaximal eccentric strength training for a subject with polymyositis","volume":"53","author":"Harris-Love","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.12.012_bib0845","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.revmed.2009.04.010","article-title":"Infections opportunistes non tuberculeuses au cours des traitements par les anti-TNF\u03b1","volume":"31","author":"Marie","year":"2010","journal-title":"Rev Med Interne"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498211000546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498211000546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T11:23:00Z","timestamp":1543922580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498211000546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":169,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0755498211000546"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2010.12.012","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}